Axolotl Biologix Patents – Insights & Stats (Updated 2023)

Axolotl Biologix has a total of 12 patents globally. Out of these 12 patents, more than 91% patents are active. The United States of America is where Axolotl Biologix has filed the maximum number of patents. Parallelly, The United States of America seems to be the main focused R&D center and also the origin country of Axolotl Biologix.

Axolotl Biologix was founded in the year 2016. Axolotl Biologix is a biotechnology company that uses technology, research, and clinical applications to create regenerative medicine.

Do read about some of the most popular patents of Axolotl Biologix which have been covered by us in this article and also you can find Axolotl Biologix patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Axolotl Biologix patent portfolio.

How many patents does Axolotl Biologix have?

Axolotl Biologix has a total of 12 patents globally. These patents belong to 1 unique patent family. Out of 12 patents, 11 patents are active.

How Many Patents did Axolotl Biologix File Every Year?

Axolotl Biologix Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAxolotl Biologix Applications FiledAxolotl Biologix Patents Granted
20224
20211
20207

How many Axolotl Biologix patents are Alive/Dead?

Worldwide Patents

Axolotl Biologix Patents Portfolio

How Many Patents did Axolotl Biologix File in Different Countries?

Axolotl Biologix Worldwide Patents

Countries in which Axolotl Biologix Filed Patents

CountryPatents
United States Of America3
Mexico1
India1
Canada1
Brazil1
New Zealand1
Chile1
Australia1
Europe1

Where are Research Centers of Axolotl Biologix Patents Located?

The Research Centre for all the Axolotl Biologix patents is the United States of America.

List of Axolotl Biologix Patents

Axolotl BiologixTitle
US20220305061A1Compositions Derived From Human Amnion Cells & Related Methods
US20220152119A1Compositions Derived From Human Amnion Cells & Related Methods
US20220133807A1Compositions Derived From Human Amnion Cells & Related Methods
EP4009993A4Compositions Derived From Human Amnion Cells & Related Methods
CA3145800A1Compositions Derived From Human Amnion Cells & Related Methods
AU2020327956A1Compositions Derived From Human Amnion Cells And Related Methods
IN202117062199ACompositions Derived From Human Amnion Cells & Related Methods
CL202200103A1Compositions Derived From Human Amnios Cells And Related Methods
MX2022001631ACompositions Derived From Human Amnion Cells & Related Methods.
BR112022000502A2Method For Preparing A Cellular Human Amnion-Derived Composition Configured For Therapeutic Use, Method For Treatment A Subject Suffering From Degenerative Joint Disease, And Human Amnion-Derived Composition
NZ784017ACompositions Derived From Human Amnion Cells & Related Methods
WO2021030292A1Compositions Derived From Human Amnion Cells & Related Methods

What are Axolotl Biologix key innovation segments?

What Technologies are Covered by Axolotl Biologix?

The chart below distributes patents filed by Axolotl Biologix in different countries on the basis of the technology protected in patents. It also represents the markets where Axolotl Biologix thinks it’s important to protect particular technology inventions.

R&D Focus: How has Axolotl Biologix search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Axolotl Biologix?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.